---
schema_version: "secwatch.filing_event.v1"
accession: "0000885978-24-000048"
form_type: "8-K"
ticker: "USPH"
cik: "0000885978"
company_name: "U S PHYSICAL THERAPY INC /NV"
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:32:30.627367+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# USPH Q2 revenue up 8.5% to $143.5M; EPS $0.47 vs $0.64; guidance reaffirmed at $80-85M EBITDA

## Summary
- GAAP net income $7.5M ($0.47 diluted EPS) vs $10.9M ($0.64) in Q2 2023; share count up from May 2023 secondary offering.
- Adjusted EBITDA $22.1M vs $21.7M; non-GAAP Operating Results $0.73/share vs $0.76.
- Total patient visits hit all-time quarterly high of 1,335,335, up 5.4%; net rate per visit $105.05 (+3.0%).
- Industrial injury prevention revenue up 23.2% to $23.7M; acquired an IIP business for $24M on April 30, 2024.
- Quarterly dividend $0.44/share declared (payable Sep 13, record Aug 23); clinic count 681 vs 656 a year ago.

## SEC filing metadata
- accession: 0000885978-24-000048
- form_type: 8-K
- ticker: USPH
- cik: 0000885978
- company_name: U S PHYSICAL THERAPY INC /NV
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885978/000088597824000048/0000885978-24-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885978/000088597824000048/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885978-24-000048
- JSON: https://secwatch.observer/filing/0000885978-24-000048.json
- Plain text: https://secwatch.observer/filing/0000885978-24-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.